Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October iito 600x60px
Document › Details

Medigene AG. (5/24/18). "Press Release: Medigene Successfully Raises EUR 32.3 Million in Oversubscribed Private Placement [NOT FOR UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICA

Organisations Organisation Medigene AG (FSE: MDG1, Prime Standard)
  Group Medigene (Group)
  Organisation 2 QVT Financial LP
  Group QVT (Group)
Products Product T cell therapy
  Product 2 investment banking
Index term Index term Medigene–SEVERAL: investment, 201805 private placement €32.3m 2.23m new shares at €14.5/share to institutional investors
Persons Person Taapken, Thomas (Medigene 201701–201808 CFO before Epigenomics + Biotie/elbion + DVC + Burrill + Hoechst LEFT 8/18)
  Person 2 Hofmann, Julia (Medigene 201604 PR/IR)
     


   
Record changed: 2018-05-31

Advertisement

Picture Sacura Get Your Substance to Market iito 600x60px

More documents for Medigene (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October iito 600x60px




» top